您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2013, Vol. 51 ›› Issue (9): 31-34.

• 基础医学 • 上一篇    下一篇

抑制EZH2基因表达的shRNA载体的构建及其作用

吕艳锋1,韩冰冰2,禹化龙1,王建新1   

  1. 1.山东大学第二医院肛肠外科,济南 250033;2.山东中医药大学微循环实验室,济南 250014
  • 收稿日期:2013-06-17 出版日期:2013-09-10 发布日期:2013-09-10
  • 通讯作者: 王建新,E-mail:youtow@sina.com
  • 基金资助:

    山东省自然科学基金(ZR2011HQ049);济南市青年科技明星计划(20090208,201004055)

Construction and effect of shRNA vector silencing EZH2 expression

Lv Yan-feng1, HAN Bing-bing2, YU Hua-long1, WANG Jian-xin1   

  1. 1.Department of Anoproctology, Second Hospital of Shandong University, Jinan  250033, China;
    2. Microcirculation Laboratory, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
  • Received:2013-06-17 Online:2013-09-10 Published:2013-09-10

摘要:

目的   构建zeste基因增强子同源物2(EZH2)靶向的小发夹RNA(shRNA)重组表达载体,探讨抑制EZH2基因表达后其在结直肠癌细胞中的作用。方法   根据EZH2cDNA序列设计具有短发夹结构的两条DNA序列,与载体pGFP-V-RS构建重组表达载体,鉴定后转染至SW480细胞。将其随机分为阴性对照组和基因沉默组,RT-PCR和蛋白质印迹法检测抑制效果,MTT法检测细胞增殖情况。结果   成功构建了抑制EZH2基因表达的干扰质粒。阴性对照组EZH2 mRNA 的表达是基因沉默组的5.8倍(P<0.01),基因沉默组EZH2的蛋白明显低于阴性对照组(P<0.05)。与阴性对照组相比,基因沉默组细胞生长受到明显抑制(P<0.05)。结论      EZH2靶向shRNA 重组表达载体构建成功,并能显著抑制EZH2基因的表达,为进一步研究EZH2基因在肿瘤中的作用机制提供了基础。

关键词: EZH2基因;RNA干扰;SW480细胞;蛋白质印迹法;MTT法

Abstract:

Objective     To construct a recombinant short hairpin RNA (shRNA) expression vector targeting enhancer of zeste homolog 2(EZH2) gene and explore its effect on colorectal cancer cells. Methods    Two DNA sequences with short hairpin structure were designed according to the EZH2 cDNA sequence and cloned into pGFP-V-RS vector to construct a recombinant expression vector silencing EZH2 gene.After identification, the shRNA-expressing vector was then transfected into SW480 cells.Then transfected SW480 cells were divided into negative control group and gene silencing group.RT-PCR and Western blotting were used to detect inhibitory effect.MTT was used to detect cell proliferation. Results   A recombinant vector harboring shRNA of EZH2 was successfully constructed in this work.With respect to assessment of interference efficiency,the expression of EZH2 mRNA in negative control group was 5.8 times (P<0.01) of that in gene silencing group. And the expression of EZH2 protein in gene silencing group was significantly lower than that in negative control group (P<0.05 ).Moreover, the cell viability in gene silencing group was significantly reduced than that in negative control group (P<0.05). Conclusion    The present study demonstrates that a recombinant shRNA expression vector targeting EZH2 gene was successfully constructed, with significant inhibitory effect on proliferation of SW480 cells. This lays an experimental foundation for further exploring the mechanism underlying the action of EZH2 gene on tumor biology.

Key words: EZH2 gene; RNA interference; SW480 cells; Western blotting; MTT zeste

中图分类号: 

  • R735.3
[1] 袁志平1,牟华平2,王秋1,王立帅1,陈洁1,张川利1,周光远1,陈家莲1. VEGF、sICAM-1蛋白在结直肠癌患者血清中的表达水平及临床意义[J]. 山东大学学报(医学版), 2013, 51(10): 74-76.
[2] 冯斐1,燕锦2,袁萍1,胡晓琴1,徐琳2,杨艳芳1. 饮食习惯、生活方式与结直肠癌关系的配对病例对照研究[J]. 山东大学学报(医学版), 2013, 51(7): 107-112.
[3] 任鹏1,郝青2,王杰书3,李洪林3,李波3,王峰3. 趋化因子受体3及血管生成拟态在结肠癌肝转移中的作用[J]. 山东大学学报(医学版), 2012, 50(8): 96-99.
[4] 张江洲1,卢小开2,冯志宇2,龙志雄1,冉立3,谭诗生2. 胃癌术后放疗三种放疗技术的剂量学比较研究[J]. 山东大学学报(医学版), 2012, 50(2): 64-69.
[5] 王开雷,李乐平,靖昌庆. 两种人大肠癌多药耐药株的建立及耐药性比较[J]. 山东大学学报(医学版), 2011, 49(4): 75-.
[6] 孔帅,李乐平,靖昌庆,王峰. RNA干扰技术沉默MDR1基因逆转大肠癌耐药细胞株LoVo/5-Fu的耐药性[J]. 山东大学学报(医学版), 2010, 48(6): 80-83.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!